Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fast-dissolving microparticles fail to show improved oral bioavailability.

S M Wong1, I W Kellaway, S Murdan

  • 1Department of Pharmaceutics, School of Pharmacy, London WC1N 1AX, UK.

The Journal of Pharmacy and Pharmacology
|October 13, 2006
PubMed
Summary

Improving oral drug bioavailability for poorly soluble drugs (Class II) is challenging. Rapidly dissolving particles did not enhance griseofulvin absorption in rats, indicating dissolution rate isn't always predictive of in-vivo performance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology.

ESMO open·2024
Same author

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Enhancing the training of community engagement officers to address vaccine hesitancy: a university and local authority collaboration.

Perspectives in public health·2023
Same author

What can GP data tell us about the treatment of onychomycosis in the UK?

Skin health and disease·2022
Same author

A drug-in-adhesive anti-onychomycotic nail patch: Influence of drug and adhesive nature on drug release, ungual permeation, in vivo residence in human and anti-fungal efficacy.

International journal of pharmaceutics·2022

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Biopharmaceutics

Background:

  • Oral dosage forms are preferred for systemic drug delivery.
  • Poor water solubility and gastrointestinal permeability hinder drug development.
  • Biopharmaceutics Classification System (BCS) Class II drugs require strategies to improve bioavailability.

Purpose of the Study:

  • To enhance the in-vivo oral bioavailability of a model BCS Class II drug, griseofulvin.
  • To investigate the effectiveness of rapidly dissolving particles prepared using the solvent-diffusion method.
  • To assess the correlation between in-vitro dissolution rate and in-vivo absorption.

Main Methods:

  • Griseofulvin particles were prepared using a solvent-diffusion method with a hydrophilic surfactant blend (Brij 76/Tween 80).

Related Experiment Videos

  • Characterization of particle size and morphology (bipyramidal habit).
  • In-vitro dissolution testing and in-vivo pharmacokinetic studies in rats.

    • Main Results:

    • Prepared particles exhibited a small size (2.18 µm) and rapid in-vitro dissolution (approx. 70% in 30 min) compared to the control (12.61 µm, approx. 10%).
    • Despite enhanced in-vitro dissolution, the in-vivo oral bioavailability of griseofulvin was not significantly improved.
    • The absorption profile in rats was similar for both the prepared particles and the control drug.

    Conclusions:

    • Rapid in-vitro dissolution of BCS Class II drugs does not always guarantee enhanced in-vivo oral bioavailability.
    • Particle size and dissolution rate alone may not be sufficient predictors of in-vivo drug performance.
    • Further investigation into factors influencing drug absorption beyond dissolution is warranted for poorly soluble compounds.